Genomic Classification of Bladder Cancer

Genomic classification of bladder cancer involves analyzing the tumor's genetic makeup to categorize it into specific subtypes based on DNA mutations and gene activity. This helps identify distinct molecular profiles that influence how the cancer behaves and responds to treatment. By understanding these genetic differences, doctors can personalize therapies, predict prognosis more accurately, and develop targeted treatments tailored to each tumor's unique genetic characteristics, improving patient outcomes.